Drug Hepatotoxicity, An Issue of Clinics in Liver Disease, 1st Edition
著者 :
By Vinod K. Rustgi, MD, MBA
Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver
...view more
Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including “human on a chip and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.
Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including “human on a chip and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.
著者情報
By Vinod K. Rustgi, MD, MBA, Distinguished Professor, Associate Program Director, Clinical Director of Hepatology, and Director, Center for Liver Diseases, Robert Wood Johnson Medical School (RWJMS), Rutgers Health, New Brunswick, NJ, USA
By Vinod K. Rustgi, MD, MBA, Distinguished Professor, Associate Program Director, Clinical Director of Hepatology, and Director, Center for Liver Diseases, Robert Wood Johnson Medical School (RWJMS), Rutgers Health, New Brunswick, NJ, USA
https://shop.elsevier.jp/drug-hepatotoxicity-an-issue-of-clinics-in-liver-disease-9780323496629.html301712Drug Hepatotoxicity, An Issue of Clinics in Liver Diseasehttps://secure-ecsd.elsevier.com/covers/80/Tango2/large/9780323496629.jpg1390313903JPYInStock/Medicine & Surgery/Gastroenterology & Hepatology/eBooks/Medicine/Gastroenterology & Hepatology/eBooks/eBooks/Medicine/Gastroenterology & Hepatology/Medicine/Gastroenterology & Hepatology/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book/Product Format/E-Book433513943887245054607505466552550405259894580354159368005936822593682759368321418269243350884886536505455351451205259833579989258035265936799593680959368235936828Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including “human on a chip and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B. Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including “human on a chip and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.00add-to-cart97803234966292016専門医By Vinod K. Rustgi, MD, MBA20171E-BookElsevier02016/11/16IN STOCKBy <STRONG>Vinod K. Rustgi</STRONG>, MD, MBA, Distinguished Professor, Associate Program Director, Clinical Director of Hepatology, and Director, Center for Liver Diseases, Robert Wood Johnson Medical School (RWJMS), Rutgers Health, New Brunswick, NJ, USAE-BookE-BookThe Clinics: Internal MedicineS013Gastroenterology & Hepatology, Medicine米国いいえいいえいいえいいえいいえ選択してください選択してくださいいいえいいえ選択してください